Obesity, diabetes, and gut microbiota: the hygiene hypothesis expanded? - PubMed (original) (raw)
Review
Obesity, diabetes, and gut microbiota: the hygiene hypothesis expanded?
Giovanni Musso et al. Diabetes Care. 2010 Oct.
Abstract
The connection between gut microbiota and energy homeostasis and inflammation and its role in the pathogenesis of obesity-related disorders are increasingly recognized. Animals models of obesity connect an altered microbiota composition to the development of obesity, insulin resistance, and diabetes in the host through several mechanisms: increased energy harvest from the diet, altered fatty acid metabolism and composition in adipose tissue and liver, modulation of gut peptide YY and glucagon-like peptide (GLP)-1 secretion, activation of the lipopolysaccharide toll-like receptor-4 axis, and modulation of intestinal barrier integrity by GLP-2. Instrumental for gut microbiota manipulation is the understanding of mechanisms regulating gut microbiota composition. Several factors shape the gut microflora during infancy: mode of delivery, type of infant feeding, hospitalization, and prematurity. Furthermore, the key importance of antibiotic use and dietary nutrient composition are increasingly recognized. The role of the Western diet in promoting an obesogenic gut microbiota is being confirmation in subjects. Following encouraging results in animals, several short-term randomized controlled trials showed the benefit of prebiotics and probiotics on insulin sensitivity, inflammatory markers, postprandial incretins, and glucose tolerance. Future research is needed to unravel the hormonal, immunomodulatory, and metabolic mechanisms underlying microbe-microbe and microbiota-host interactions and the specific genes that determine the health benefit derived from probiotics. While awaiting further randomized trials assessing long-term safety and benefits on clinical end points, a healthy lifestyle--including breast lactation, appropriate antibiotic use, and the avoidance of excessive dietary fat intake--may ensure a friendly gut microbiota and positively affect prevention and treatment of metabolic disorders.
Similar articles
- Gut microbiota as a regulator of energy homeostasis and ectopic fat deposition: mechanisms and implications for metabolic disorders.
Musso G, Gambino R, Cassader M. Musso G, et al. Curr Opin Lipidol. 2010 Feb;21(1):76-83. doi: 10.1097/MOL.0b013e3283347ebb. Curr Opin Lipidol. 2010. PMID: 19915460 Review. - Gut microbiota controls adipose tissue expansion, gut barrier and glucose metabolism: novel insights into molecular targets and interventions using prebiotics.
Geurts L, Neyrinck AM, Delzenne NM, Knauf C, Cani PD. Geurts L, et al. Benef Microbes. 2014 Mar;5(1):3-17. doi: 10.3920/BM2012.0065. Benef Microbes. 2014. PMID: 23886976 Review. - The gut microbiota, obesity and insulin resistance.
Shen J, Obin MS, Zhao L. Shen J, et al. Mol Aspects Med. 2013 Feb;34(1):39-58. doi: 10.1016/j.mam.2012.11.001. Epub 2012 Nov 16. Mol Aspects Med. 2013. PMID: 23159341 Review. - [Physiological patterns of intestinal microbiota. The role of dysbacteriosis in obesity, insulin resistance, diabetes and metabolic syndrome].
Halmos T, Suba I. Halmos T, et al. Orv Hetil. 2016 Jan 3;157(1):13-22. doi: 10.1556/650.2015.30296. Orv Hetil. 2016. PMID: 26708682 Review. Hungarian. - Targeting gut microbiota in obesity: effects of prebiotics and probiotics.
Delzenne NM, Neyrinck AM, Bäckhed F, Cani PD. Delzenne NM, et al. Nat Rev Endocrinol. 2011 Aug 9;7(11):639-46. doi: 10.1038/nrendo.2011.126. Nat Rev Endocrinol. 2011. PMID: 21826100 Review.
Cited by
- Epigallocatechin-3-Gallate and Genistein for Decreasing Gut Dysbiosis, Inhibiting Inflammasomes, and Aiding Autophagy in Alzheimer's Disease.
Muraleedharan A, Ray SK. Muraleedharan A, et al. Brain Sci. 2024 Jan 19;14(1):96. doi: 10.3390/brainsci14010096. Brain Sci. 2024. PMID: 38275516 Free PMC article. Review. - Cesarean section and increased body mass index in school children: two cohort studies from distinct socioeconomic background areas in Brazil.
Goldani MZ, Barbieri MA, da Silva AA, Gutierrez MR, Bettiol H, Goldani HA. Goldani MZ, et al. Nutr J. 2013 Jul 25;12:104. doi: 10.1186/1475-2891-12-104. Nutr J. 2013. PMID: 23886115 Free PMC article. - Revealing the Impact of Gut Microbiota on Acne Through Mendelian Randomization Analysis.
Ji X, Wu S, Zhao D, Bai Q, Wang Y, Gong K, Zheng H, Zhu M. Ji X, et al. Clin Cosmet Investig Dermatol. 2024 Feb 8;17:383-393. doi: 10.2147/CCID.S451104. eCollection 2024. Clin Cosmet Investig Dermatol. 2024. PMID: 38348088 Free PMC article. - Probiotics and yogurt modulate oxidative stress and fibrosis in livers of Schistosoma mansoni-infected mice.
El-Khadragy MF, Al-Olayan EM, Elmallah MIY, Alharbi AM, Yehia HM, Abdel Moneim AE. El-Khadragy MF, et al. BMC Complement Altern Med. 2019 Jan 3;19(1):3. doi: 10.1186/s12906-018-2406-3. BMC Complement Altern Med. 2019. PMID: 30606163 Free PMC article. - Microbial influences on gut development and gut-brain communication.
Ye L, Rawls JF. Ye L, et al. Development. 2021 Nov 1;148(21):dev194936. doi: 10.1242/dev.194936. Epub 2021 Nov 10. Development. 2021. PMID: 34758081 Free PMC article. Review.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical